Skip to content
Screener

GRAIL, Inc. GRAL Price / book

Price / book at other companies

Abbott logo
AbbottABT
3.1×-1.7×
Guardant Health logo
Guardant HealthGH
36.8×—
Natera, Inc. logo
Natera, Inc.NTRA
21.3×+2.5×
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
23.4×-14.8×
Myriad Genetics logo
Myriad GeneticsMYGN
1.2×+0.1×
Personalis, Inc. logo
Personalis, Inc.PSNL
2.6×+1.1×

Other financials

Income statement

See full
Revenue$44.7M+25.7%
Operating income-$173.8M-9.4%
Net income-$110.2M+3.3%
EPS (diluted)-$2.56+19.5%

Balance sheet

See full
Cash & equivalents$62.6M-52.1%
Total debt$91.3M+46.9%
Total equity$2.5B+9.9%
Total assets$2.8B+5.2%

Cash flow

See full
Operating cash flow-$80.7M-4.9%
CapEx$432.0K+17.1%
Free cash flow-$81.2M-4.9%

Valuation

See full
Market cap$2.72B+129%
Enterprise value$2.75B+145%
P/S16.5×+7.6×

Profitability

See full
Operating margin-338.4%-74.4pp
Net margin-236.9%-52.1pp
FCF margin-179.2%-46.7pp

Returns & leverage

See full
Return on equity-16.1%-1.3pp
Debt / equity0×0.0×
Current ratio10.9×+1.7×

Where this comes from

Calculated from GRAIL, Inc.’s reported figures.

market cap/total stockholders equity=1.2×

Based on the most recent quarter.

The source filing: GRAIL, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054307

FAQ

What is GRAIL, Inc.'s price / book?
GRAIL, Inc. (GRAL) reported price / book of 1.2× in Q2 2026.
How has GRAIL, Inc.'s price / book changed year-over-year?
GRAIL, Inc.'s price / book increased by 68.7% year-over-year, from 0.7× to 1.2×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about GRAIL, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude